UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 2016
JAGUAR ANIMAL HEALTH, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-36714 |
|
46-2956775 |
|
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
201 Mission Street, Suite 2375 |
|
94105 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (415) 371-8300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Resignation of Chief Veterinary Officer
On June 16, 2016, Philippe Brianceau submitted his resignation, effective immediately, as Chief Veterinary Officer of Jaguar Animal Health, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
JAGUAR ANIMAL HEALTH, INC. | ||
|
|
| ||
|
|
| ||
|
|
By: |
/s/ Karen S. Wright | |
|
|
|
Name: |
Karen S. Wright |
|
|
|
Title: |
Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
Date: June 21, 2016 |
|
|
|